BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 19564498)

  • 1. Neutralizing monoclonal antibody sandwich liquid-phase blocking enzyme-linked immunosorbent assay for detection of Foot-and-mouth disease virus type O antibodies.
    Morioka K; Fukai K; Yoshida K; Yamazoe R; Onozato H; Ohashi S; Tsuda T; Sakamoto K
    J Vet Diagn Invest; 2009 Jul; 21(4):499-503. PubMed ID: 19564498
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Implication of Broadly Neutralizing Bovine Monoclonal Antibodies in the Development of an Enzyme-Linked Immunosorbent Assay for Detecting Neutralizing Antibodies against Foot-and-Mouth Disease Virus Serotype O.
    Cao Y; Li K; Wang S; Fu Y; Sun P; Li P; Bai X; Zhang J; Ma X; Xing X; Zhou S; Bao H; Li D; Chen Y; Li Z; Lu Z; Liu Z
    J Clin Microbiol; 2019 Dec; 57(12):. PubMed ID: 31578261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative evaluation of three commercial ELISA kits for detection of antibodies to a nonstructural protein of foot-and-mouth disease virus.
    Fukai K; Morioka K; Onozato H; Yoshida K; Sakamoto K
    J Vet Med Sci; 2013; 75(6):693-9. PubMed ID: 23328606
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A solid-phase blocking ELISA for detection of type O foot-and-mouth disease virus antibodies suitable for mass serology.
    Chénard G; Miedema K; Moonen P; Schrijver RS; Dekker A
    J Virol Methods; 2003 Jan; 107(1):89-98. PubMed ID: 12445942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An improved, rapid competitive ELISA using a novel conserved 3B epitope for the detection of serum antibodies to foot-and-mouth disease virus.
    Chung CJ; Clavijo A; Bounpheng MA; Uddowla S; Sayed A; Dancho B; Olesen IC; Pacheco J; Kamicker BJ; Brake DA; Bandaranayaka-Mudiyanselage CL; Lee SS; Rai DK; Rieder E
    J Vet Diagn Invest; 2018 Sep; 30(5):699-707. PubMed ID: 29916768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative single dilution liquid phase blocking ELISA for sero-monitoring of foot-and-mouth disease in India.
    Sharma GK; Mahajan S; Matura R; Subramaniam S; Mohapatra JK; Pattnaik B
    Biologicals; 2015 May; 43(3):158-64. PubMed ID: 25911541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and validation of a solid-phase competition ELISA based on virus-like particles of foot-and-mouth disease virus serotype A for antibody detection.
    Zhang Y; Yan H; Yao Y; Zhang S; Xiao Y; Xu X; Huang B; Tian K
    Arch Virol; 2020 Jul; 165(7):1641-1646. PubMed ID: 32350612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of an epitope-blocking-enzyme-linked immunosorbent assay to differentiate between animals infected with and vaccinated against foot-and-mouth disease virus.
    Oem JK; Chang BS; Joo HD; Yang MY; Kim GJ; Park JY; Ko YJ; Kim YJ; Park JH; Joo YS
    J Virol Methods; 2007 Jun; 142(1-2):174-81. PubMed ID: 17336400
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Performance characteristics of virus neutralization test (VNT) and liquid phase blocking ELISA (LPBE) and their relationship in the cattle immunized with trivalent foot and mouth disease vaccine.
    Selvan RT; Sreenivasa BP; Hosamani M; Basagoudanavar SH; P S; Venkataramanan R
    Vet Ital; 2021 Jul; 57(2):. PubMed ID: 34971502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation and optimization of a conventional SPCE for FMD post-vaccination monitoring.
    Kang YL; Jeong JY; Choi HY; Zhang Y; Liu Y; Lee HJ; Choi JC; Lee SH; Lee BJ; Lee SW; Lee JB; Cho KH; Park SY
    BMC Vet Res; 2018 Nov; 14(1):371. PubMed ID: 30486820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of antibodies against foot-and-mouth disease virus using a liquid-phase blocking sandwich ELISA (LPBE) with a bioengineered 3D protein.
    O'Donnell VK; Boyle DB; Sproat K; Fondevila NA; Forman A; Schudel AA; Smitsaart EN
    J Vet Diagn Invest; 1996 Apr; 8(2):143-50. PubMed ID: 8744733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monoclonal antibody based solid phase competition ELISA to detect FMDV serotype A specific antibodies.
    Hema Sayee R; Hosamani M; Krishnaswamy N; Shanmuganathan S; Nagasupreeta SR; Sri Sai Charan M; Sheshagiri G; Gairola V; Basagoudanavar SH; Sreenivasa BP; Bhanuprakash V
    J Virol Methods; 2024 Jul; 328():114959. PubMed ID: 38788979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serological evidence indicates that foot-and-mouth disease virus serotype O, C and SAT1 are most dominant in eritrea.
    Tekleghiorghis T; Moormann RJ; Weerdmeester K; Dekker A
    Transbound Emerg Dis; 2014 Dec; 61(6):e83-8. PubMed ID: 23480728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generation of mAbs to foot-and-mouth disease virus serotype A and application in a competitive ELISA for serodiagnosis.
    Yang M; Xu W; Bittner H; Horsington J; Vosloo W; Goolia M; Lusansky D; Nfon C
    Virol J; 2016 Nov; 13(1):195. PubMed ID: 27894355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Application of the Ceditest® FMDV type O and FMDV-NS enzyme-linked immunosorbent assays for detection of antibodies against Foot-and-mouth disease virus in selected livestock and wildlife species in Uganda.
    Ayebazibwe C; Mwiine FN; Balinda SN; Tjørnehøj K; Alexandersen S
    J Vet Diagn Invest; 2012 Mar; 24(2):270-6. PubMed ID: 22379044
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of seroreagents to FMDV in the cattle population in Poland: results of 9-year monitoring studies.
    Niedbalski W
    Pol J Vet Sci; 2003; 6(1):1-5. PubMed ID: 12675463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the solid phase competition ELISA for detecting antibodies against the six foot-and-mouth disease virus non-O serotypes.
    Li Y; Swabey KG; Gibson D; Keel PJ; Hamblin P; Wilsden G; Corteyn M; Ferris NP
    J Virol Methods; 2012 Aug; 183(2):125-31. PubMed ID: 22561986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and validation of a 3ABC indirect ELISA for differentiation of foot-and-mouth disease virus infected from vaccinated animals.
    Lu Z; Cao Y; Guo J; Qi S; Li D; Zhang Q; Ma J; Chang H; Liu Z; Liu X; Xie Q
    Vet Microbiol; 2007 Nov; 125(1-2):157-69. PubMed ID: 17601688
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Foot-and-mouth disease virus antigen detection enzyme-linked immunosorbent assay using multiserotype-reactive monoclonal antibodies.
    Morioka K; Fukai K; Yoshida K; Yamazoe R; Onozato H; Ohashi S; Tsuda T; Sakamoto K
    J Clin Microbiol; 2009 Nov; 47(11):3663-8. PubMed ID: 19759230
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liquid-phase blocking sandwich enzyme-linked immunosorbent assay for detection of antibodies against foot-and-mouth disease virus in water buffalo sera.
    Araújo JP; Montassier HJ; Pinto AA
    Am J Vet Res; 1996 Jun; 57(6):840-3. PubMed ID: 8725810
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.